Erik Hess
Critical Care Medicine Nashville, TN Medical Doctor
NPI 1518932292 CMS profile 1260105
3601 The Vanderbilt Clinic, Nashville, TN 37232
General payments
$14,341
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$99
Through program year 2019, Erik Hess of Nashville, TN is reported in the CMS Open Payments database as having received $14,341 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $99 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $14,341 | 1 |
Beside peers
- Erik Hess
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Erik Hess were reported at $0. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Erik Hess | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $14,341 | $149 | $51–$535 | $163 |
| 2020 | $0 | $110 | $30–$325 | $114 |
| 2021 | $0 | $125 | $34–$403 | $132 |
| 2022 | $0 | $157 | $49–$582 | $149 |
| 2023 | $0 | $162 | $56–$621 | $160 |
| 2024 | $0 | $168 | $53–$634 | $164 |
| 2025 | $0 | $189 | $59–$844 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 13 billing codesPaid by Medicare
$17,546
Medicare patients
144
Services billed
155
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 56% | |
| Chronic kidney disease | 42% | |
| Ischemic heart disease | 40% | |
| Depression | 39% | |
| Diabetes | 35% | |
| Atrial fibrillation | 34% | |
| Heart failure | 30% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in Tennessee
Gordon Bernard
Critical Care Medicine · Nashville, TN
Todd Rice
Critical Care Medicine · Nashville, TN
Jeffery Nelson
Critical Care Medicine · Maryville, TN
Jeremy Greenberg
Critical Care Medicine · Chattanooga, TN
Anthony Mattox
Critical Care Medicine · Memphis, TN
Ann Gage
Critical Care Medicine · Nashville, TN
Related records
Critical Care Medicine in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.